Morpholine compounds

Details for Australian Patent Application No. 2005237301 (hide)

Owner Pfizer, Inc.

Inventors MacKenny, Malcolm Christian; Whitlock, Gavin Alistair; Wakenhut, Florian; Stobie, Alan; Fish, Paul Vincent

Agent Allens Arthur Robinson

Pub. Number AU-A-2005237301

PCT Pub. Number WO2005/105100

Priority 0409744.0 30.04.04 GB

Filing date 20 April 2005

Wipo publication date 10 November 2005

International Classifications

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Event Publications

19 October 2006 PCT application entered the National Phase

  PCT publication WO2005/105100 Priority application(s): WO2005/105100

26 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005237307-Process for seeding a media with microorganism in form of a tablet

2005237290-Compositions for progeny gender control